跳至主要内容
临床试验/NCT00752141
NCT00752141已完成1 期

Cognitive Effects of Oral Oxybutynin and Oxybutynin Chloride Topical Gel in Older Volunteers

Watson Pharmaceuticals0 个研究点目标入组 153 人开始时间: 2008年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
153
主要终点
Measure of accuracy of delayed recall name-phase association test

研究概览

简要总结

The purpose of this study is to explore the possible cognitive effects of oxybutynin tablets and oxybutynin gel.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
60 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females aged 60 and over
  • English as a primary language
  • Given written informed consent by signing and dating an informed consent form prior to study entry

排除标准

  • Current diseases in which the use of oxybutynin is contraindicated
  • History of narrow-angle glaucoma or urinary or gastric retention
  • Current use of drugs known to effect memory and cognition
  • Other protocol-defined inclusion/exclusion criteria may apply

研究组 & 干预措施

1

Experimental

oral oxybutynin

干预措施: oxybutynin chloride immediate-release (Drug)

2

Experimental

oxybutynin topical gel

干预措施: oxybutynin chloride topical gel (Drug)

3

Placebo Comparator

placebo tablets plus placebo gel

干预措施: placebo (Other)

结局指标

主要结局

Measure of accuracy of delayed recall name-phase association test

时间窗: one week

次要结局

  • Effects on other cognitive domains measured by various tests(one week)

研究者

发起方
Watson Pharmaceuticals
申办方类型
Industry
责任方
Sponsor

相似试验